This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
$0.03461
Share price
0.00%
Change (1 day)
-99.26%
Change (1 year)
Categories
Revenue for ViewRay (VRAY)
Revenue in 2023 (TTM): C$0.14 Billion
According to ViewRay's latest financial reports the company's current revenue (TTM 
) is C$0.14 Billion. In 2022 the company made a revenue of C$0.13 Billion an increase over the revenue in the year 2021 that were of C$89.36 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ViewRay from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | C$0.14 B | 2.61% |
| 2022 | C$0.13 B | 55.2% |
| 2021 | C$89.36 M | 22.92% |
| 2020 | C$72.7 M | -36.59% |
| 2019 | C$0.11 B | 3.96% |
| 2018 | C$0.11 B | 157.68% |
| 2017 | C$42.79 M | 43.22% |
| 2016 | C$29.88 M | 116.98% |
| 2015 | C$13.77 M | |
| 2014 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | C$0.14 B | 0.00% | 🇺🇸 USA |
 | C$1.13 B | 675.33% | 🇺🇸 USA |
 | C$14.78 M | -89.91% | 🇮🇱 Israel |